Why Viking Therapeutics Stock More Is Turning Heads Today
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesToday’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
Mortgage rates rose again this week as inflation fears and geopolitical tensions weighed on bonds. The latest Freddie...
Uber is dialing back its push on wide AI bets, choosing measured investments aimed at ROI and platform reliability. T...
Micron Technology stock sits at the crossroads of AI memory demand and a broader semiconductor pullback. This guide w...
Fox faced a sharp weekly decline as it moved to acquire Roku. This article breaks down the catalysts, financing, and ...
CoreWeave surged after its IPO, then pulled back. This guide breaks down how to think about buying the dip, with real...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...